vs

Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and iPower Inc. (IPW). Click either name above to swap in a different company.

Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $12.0M, roughly 1.1× iPower Inc.). On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -36.8%).

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.

American Electric Power Company, Inc. is an American domestic electric utility company in the United States. It is one of the largest electric utility companies in the country, with more than five million customers in 11 states.

GOSS vs IPW — Head-to-Head

Bigger by revenue
GOSS
GOSS
1.1× larger
GOSS
$13.8M
$12.0M
IPW
Growing faster (revenue YoY)
GOSS
GOSS
+83.9% gap
GOSS
47.1%
-36.8%
IPW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GOSS
GOSS
IPW
IPW
Revenue
$13.8M
$12.0M
Net Profit
$-47.2M
Gross Margin
40.0%
Operating Margin
-333.6%
-14.1%
Net Margin
-342.3%
Revenue YoY
47.1%
-36.8%
Net Profit YoY
-43.0%
EPS (diluted)
$-0.21
$-0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GOSS
GOSS
IPW
IPW
Q4 25
$13.8M
Q3 25
$13.3M
$12.0M
Q2 24
$95.8M
Q1 24
$0
Q3 23
$0
Q2 23
$0
Net Profit
GOSS
GOSS
IPW
IPW
Q4 25
$-47.2M
Q3 25
$-48.2M
Q2 24
$49.2M
Q1 24
$-41.9M
Q3 23
$-40.0M
Q2 23
$-42.5M
Gross Margin
GOSS
GOSS
IPW
IPW
Q4 25
Q3 25
40.0%
Q2 24
Q1 24
Q3 23
Q2 23
Operating Margin
GOSS
GOSS
IPW
IPW
Q4 25
-333.6%
Q3 25
-369.4%
-14.1%
Q2 24
54.3%
Q1 24
Q3 23
Q2 23
Net Margin
GOSS
GOSS
IPW
IPW
Q4 25
-342.3%
Q3 25
-362.7%
Q2 24
51.4%
Q1 24
Q3 23
Q2 23
EPS (diluted)
GOSS
GOSS
IPW
IPW
Q4 25
$-0.21
Q3 25
$-0.21
$-0.51
Q2 24
$0.22
Q1 24
$-0.19
Q3 23
$-0.21
Q2 23
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GOSS
GOSS
IPW
IPW
Cash + ST InvestmentsLiquidity on hand
$136.9M
$904.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$-122.8M
$17.9M
Total Assets
$172.2M
$28.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GOSS
GOSS
IPW
IPW
Q4 25
$136.9M
Q3 25
$180.2M
$904.0K
Q2 24
$354.5M
Q1 24
$244.4M
Q3 23
$328.9M
Q2 23
$162.1M
Stockholders' Equity
GOSS
GOSS
IPW
IPW
Q4 25
$-122.8M
Q3 25
$-82.3M
$17.9M
Q2 24
$81.5M
Q1 24
$26.7M
Q3 23
$104.6M
Q2 23
$-62.8M
Total Assets
GOSS
GOSS
IPW
IPW
Q4 25
$172.2M
Q3 25
$208.8M
$28.6M
Q2 24
$373.4M
Q1 24
$259.4M
Q3 23
$347.9M
Q2 23
$181.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GOSS
GOSS
IPW
IPW
Operating Cash FlowLast quarter
$-48.3M
$1.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GOSS
GOSS
IPW
IPW
Q4 25
$-48.3M
Q3 25
$-36.2M
$1.7M
Q2 24
$116.3M
Q1 24
$-52.3M
Q3 23
$-34.5M
Q2 23
$-38.3M
Capex Intensity
GOSS
GOSS
IPW
IPW
Q4 25
0.0%
Q3 25
0.0%
Q2 24
0.0%
Q1 24
Q3 23
Q2 23
Cash Conversion
GOSS
GOSS
IPW
IPW
Q4 25
Q3 25
Q2 24
2.36×
Q1 24
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GOSS
GOSS

Segment breakdown not available.

IPW
IPW

Products$10.5M87%
Services$1.5M13%

Related Comparisons